HIV-associated antiretroviral toxic neuropathy (ATN) : a review of recent advances in pathophysiology and treatmentYOULE, Mike.Antiviral therapy (London). 2005, Vol 10, pp M125-M129, issn 1359-6535, SUP2Conference Paper

Strategies of HIV management: when to startYOULE, Mike.AIDS (London). 2002, Vol 16, pp S145-S155, issn 0269-9370, SUP4Article

Overview of boosted protease inhibitors in treatment-experienced HIV-infected patientsYOULE, Mike.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 6, pp 1195-1205, issn 0305-7453, 11 p.Article

Salvage treatment in HIV diseaseYOULE, Mike.International journal of STD & AIDS. 2001, Vol 12, Num 5, pp 286-293, issn 0956-4624Article

Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?YOULE, Mike; WAINBERG, Mark A.AIDS (London). 2003, Vol 17, Num 6, pp 937-938, issn 0269-9370, 2 p.Article

Acetyl-l-carnitine in HIV-associated antiretroviral toxic neuropathyYOULE, Mike.CNS drugs. 2007, Vol 21, pp 25-30, issn 1172-7047, 6 p., SUP1Article

Systemic acetyl-L-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve traumaHART, Andrew Mckay; WIBERG, Mikael; YOULE, Mike et al.Experimental brain research. 2002, Vol 145, Num 2, pp 182-189, issn 0014-4819, 8 p.Article

Transient increase in plasma HIV-1 viral load and associated weight gain after thalidomide dosingTEO, Steve; NOORMOHAMED, Faruq; YOULE, Mike et al.AIDS (London). 2002, Vol 16, Num 17, pp 2355-2356, issn 0269-9370, 2 p.Article

Resolution of azole-resistant oesophageal candidiasis in an AIDS patient after treatment with caspofunginSMITH, Kate; YOULE, Mike; BAKER, Bob et al.AIDS (London). 2003, Vol 17, Num 3, pp 448-449, issn 0269-9370, 2 p.Article

Measuring the effect of clinical guidelines on patient outcomes : Clinical practice guidelines in the 21st centuryMARSHALL, Deborah A; SIMPSON, Kit N; NORTON, Edward C et al.International journal of technology assessment in health care. 2000, Vol 16, Num 4, pp 1013-1023, issn 0266-4623Article

Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-infected adultsSCHIPANI, Alessandro; EGAN, Deirdre; DICKINSON, Laura et al.Antiviral therapy (London). 2012, Vol 17, Num 5, pp 861-868, issn 1359-6535, 8 p.Article

Acetyl-I-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathyHART, Andrew M; WILSON, Andrew D. H; MONTOVANI, Cristina et al.AIDS (London). 2004, Vol 18, Num 11, pp 1549-1560, issn 0269-9370, 12 p.Article

TILT : a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individualsANGUS, Brian; LAMPE, Fiona; BABIKER, Abdul et al.AIDS (London). 2008, Vol 22, Num 6, pp 737-740, issn 0269-9370, 4 p.Article

A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen : The COLATE trialFOX, Zoe; DRAGSTED, Ulrik B; CLUMECK, Nathan et al.Antiviral therapy (London). 2006, Vol 11, Num 6, pp 761-770, issn 1359-6535, 10 p.Article

A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients : the MaxCmin2 trialDRAGSTED, Ulrik B; GERSTOFT, Jan; GAZZARD, Brian et al.Antiviral therapy (London). 2005, Vol 10, Num 6, pp 735-743, issn 1359-6535, 9 p.Article

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapySABIN, Caroline A; SMITH, Colette J; GUMLEY, Helen et al.AIDS (London). 2004, Vol 18, Num 16, pp 2145-2151, issn 0269-9370, 7 p.Article

The potential for CD4 cell increases in hiv-positive individuals who control viraemia with highly active antiretroviral therapySMITH, Colette J; SABIN, Caroline A; LAMPE, Fiona C et al.AIDS (London). 2003, Vol 17, Num 7, pp 963-969, issn 0269-9370, 7 p.Article

Health-Related Quality of Life in a Randomized Trial of Anti retroviral Therapy for Advanced HIV DiseaseJOYCE, Vilija R; BARNETT, Paul G; YOULE, Mike et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 1, pp 27-36, issn 1525-4135, 10 p.Article

Changes over time in risk of initial virological failure of combination antiretroviral therapy : A multicohort analysis, 1996 to 2002LAMPE, Fiona C; GATELL, Jose M; KRENTZ, Hartmut B et al.Archives of internal medicine (1960). 2006, Vol 166, Num 5, pp 521-528, issn 0003-9926, 8 p.Article

Emergence of CXCR4-Using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-Using virus reservoirWESTBY, Mike; LEWIS, Marilyn; WHITCOMB, Jeannette et al.Journal of virology. 2006, Vol 80, Num 10, pp 4909-4920, issn 0022-538X, 12 p.Article

Thalidomide is distributed into human semen after oral dosingTEO, Steve K; HARDEN, Jill L; BURKE, Alison B et al.Drug metabolism and disposition. 2001, Vol 29, Num 10, pp 1355-1357, issn 0090-9556Article

Stability of antiretroviral regimens in patients with viral suppressionLODWICK, Rebecca K; SMITH, Colette J; YOULE, Mike et al.AIDS (London). 2008, Vol 22, Num 9, pp 1039-1046, issn 0269-9370, 8 p.Article

Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004LAMPE, Fiona C; SMITH, Colette J; MADGE, Sara et al.Archives of internal medicine (1960). 2007, Vol 167, Num 7, pp 692-700, issn 0003-9926, 9 p.Article

Deaths in the era of HAART : contribution of late presentation, treatment exposure, resistance and abnormal laboratory markersSABIN, Caroline A; SMITH, Colette J; YOULE, Mike et al.AIDS (London). 2006, Vol 20, Num 1, pp 67-71, issn 0269-9370, 5 p.Article

Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?MOORE, Antonia L; YOULE, Mike; LOVEDAY, Clive et al.AIDS (London). 2002, Vol 16, Num 4, pp 615-618, issn 0269-9370Article